{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:21Z","timestamp":1793390841925,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clinme.2025.100298","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T23:20:44Z","timestamp":1740266444000},"page":"100298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3022-5609","authenticated-orcid":false,"given":"Maria S","family":"Varughese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6502-698X","authenticated-orcid":false,"given":"Fidelma","family":"O'Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1976-8071","authenticated-orcid":false,"given":"Lakshminarayanan","family":"Varadhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2025.100298_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.clinme.2025.100298_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000759","article-title":"Antidiabetic medication use during pregnancy: an international utilization study","volume":"7","author":"Cesta","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Suppl 1","key":"10.1016\/j.clinme.2025.100298_bib0003","first-page":"S282","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.clinme.2025.100298_bib0004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"8","key":"10.1016\/j.clinme.2025.100298_bib0005","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic Ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.clinme.2025.100298_bib0006","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s40265-022-01779-z","article-title":"The effect of oral antidiabetic drugs on improving the endocrine and metabolic states in women with polycystic ovary syndrome: a systematic review and network meta-analysis","volume":"82","author":"Yang","year":"2022","journal-title":"Drugs."},{"issue":"11","key":"10.1016\/j.clinme.2025.100298_bib0007","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.17219\/acem\/151695","article-title":"GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: current research and future horizons","volume":"31","author":"Papaetis","year":"2022","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.clinme.2025.100298_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821989238","article-title":"The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence","volume":"12","author":"Abdalla","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.clinme.2025.100298_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116150","article-title":"Efficacy and safety of GLP-1Ras for people with obesity: a systematic review based on RCT and bayesian network meta-analysis","volume":"171","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinme.2025.100298_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Lewis-Barned N on behalf of the National Pregnancy in Diabetes (NPID) advisory group","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinme.2025.100298_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102181","article-title":"Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"64","author":"Caruso","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.clinme.2025.100298_bib0012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern Med."},{"issue":"4","key":"10.1016\/j.clinme.2025.100298_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.clinme.2025.100298_bib0014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/TEN.0b013e3181a5875e","article-title":"Case report: exenatide use during pregnancy","volume":"19","author":"Williams","year":"2009","journal-title":"Endocrinologist"},{"key":"10.1016\/j.clinme.2025.100298_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.clinme.2025.100298_bib0016","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/dme.12726","article-title":"Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with type 2 diabetes","volume":"32","author":"Greco","year":"2015","journal-title":"Diabet Med"},{"issue":"3-4","key":"10.1016\/j.clinme.2025.100298_bib0017","first-page":"70","article-title":"Pregnancy outcome and liraglutide levels in serum and umbilical vein blood of a woman with type 2 diabetes: a case report","volume":"27","author":"Ivani\u0161evi\u0107","year":"2018","journal-title":"Gynaecol Perinatol"},{"issue":"2","key":"10.1016\/j.clinme.2025.100298_bib0018","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijgo.15092","article-title":"Semaglutide and pregnancy","volume":"163","author":"Skov","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.clinme.2025.100298_bib0019","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00592-022-01954-4","article-title":"A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus","volume":"60","author":"Burlina","year":"2023","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.clinme.2025.100298_bib0020","first-page":"e44644","article-title":"A case report of a pregnant woman with type 2 diabetes mellitus using dulaglutide during the first trimester of pregnancy","volume":"15","author":"Alghamdi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clinme.2025.100298_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-024-02331-z","article-title":"Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy","author":"Molteni","year":"2024","journal-title":"Acta Diabetol"},{"issue":"10","key":"10.1016\/j.clinme.2025.100298_bib0022","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/0118715303252109231023115112","article-title":"Case series: exposure to glucagon-like peptide-1 receptor agonist in the first trimester of pregnancy in two siblings","volume":"24","author":"Do\u011fan","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.clinme.2025.100298_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clinme.2025.100298_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11892-021-01409-0","article-title":"Metformin in pregnancy for women with type 2 diabetes: a review","volume":"21","author":"Benham","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.clinme.2025.100298_bib0025","doi-asserted-by":"crossref","first-page":"e14700","DOI":"10.1111\/dme.14700","article-title":"Metformin for pregnancy and beyond: the pros and cons","volume":"39","author":"Newman","year":"2022","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.clinme.2025.100298_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002363","article-title":"Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study","volume":"10","author":"Brand","year":"2022","journal-title":"BMJ Open Diab Res Care"},{"issue":"3","key":"10.1016\/j.clinme.2025.100298_bib0027","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajog.2024.02.316","article-title":"Metformin in pregnancy and childhood neurodevelopmental outcomes: a systematic review and meta-analysis","volume":"231","author":"Gordon","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.clinme.2025.100298_bib0028","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2362.2005.01542.x","article-title":"Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males","volume":"35","author":"Jeibmann","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"10.1016\/j.clinme.2025.100298_bib0029","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2174\/1381612822666151209151550","article-title":"Male fertility and obesity: are ghrelin, leptin and glucagon-like peptide-1 pharmacologically relevant?","volume":"22","author":"Alves","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.clinme.2025.100298_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/medicina60010050","article-title":"Impact of GLP-1 agonists on male reproductive health: a narrative review","volume":"60","author":"Varnum","year":"2023","journal-title":"Medicina (Kaunas)."},{"issue":"4","key":"10.1016\/j.clinme.2025.100298_bib0031","doi-asserted-by":"crossref","first-page":"bqaa031","DOI":"10.1210\/endocr\/bqaa031","article-title":"Human sperm express the receptor for glucagon-like peptide-1 (GLP-1), which affects sperm function and metabolism","volume":"161","author":"Rago","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.clinme.2025.100298_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2025.01.019","article-title":"Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes","author":"Imbroane","year":"2025","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:52:26Z","timestamp":1744447946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211825000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1470211825000168"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100298","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100298"}}